These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11596996)

  • 1. Future perspectives for Tay-Sachs disease.
    Desnick RJ; Kaback MM
    Adv Genet; 2001; 44():349-56. PubMed ID: 11596996
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessons from the American Tay-Sachs Programme.
    Steele MW
    Lancet; 1980 Oct; 2(8200):914. PubMed ID: 6107561
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for carriers of Tay-Sachs disease: two approaches.
    Clarke JT
    Can Med Assoc J; 1978 Sep; 119(6):549-50. PubMed ID: 709442
    [No Abstract]   [Full Text] [Related]  

  • 4. Carrier screening for Tay-Sachs.
    Ellis I
    Nursing (Lond); 1991 Sep 12-25; 4(41):16-8. PubMed ID: 1945106
    [No Abstract]   [Full Text] [Related]  

  • 5. Fighting tay-sachs disease.
    Trevelyan J
    Nurs Times; 1989 Jun 14-20; 85(24):22-3. PubMed ID: 2748385
    [No Abstract]   [Full Text] [Related]  

  • 6. Tay-Sachs disease: knowledge and attitudes of the rabbinical community.
    Abuelo DN; Rosenstein J; Sheff M
    R I Med J (1976); 1985 May; 68(5):225-6. PubMed ID: 3859903
    [No Abstract]   [Full Text] [Related]  

  • 7. Carrier parents of Tay Sachs disease and beta-thalassemia.
    Shah B; Bhavsar R
    Indian Pediatr; 2005 May; 42(5):498-9. PubMed ID: 15923705
    [No Abstract]   [Full Text] [Related]  

  • 8. Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease.
    Vu M; Li R; Baskfield A; Lu B; Farkhondeh A; Gorshkov K; Motabar O; Beers J; Chen G; Zou J; Espejo-Mojica AJ; Rodríguez-López A; Alméciga-Díaz CJ; Barrera LA; Jiang X; Ory DS; Marugan JJ; Zheng W
    Orphanet J Rare Dis; 2018 Sep; 13(1):152. PubMed ID: 30220252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric aspects of the adult variant of Tay-Sachs disease.
    MacQueen GM; Rosebush PI; Mazurek MF
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):10-9. PubMed ID: 9547461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rabbi's dilemma. [Interview by Alison George].
    Ekstein J
    New Sci; 2004 Feb 14-20; 181(2434):44-7. PubMed ID: 15085821
    [No Abstract]   [Full Text] [Related]  

  • 11. Tay-Sachs disease.
    Gelbart M
    Nurs Times; 1998 Mar 18-24; 94(11):39. PubMed ID: 9697531
    [No Abstract]   [Full Text] [Related]  

  • 12. Tay-Sachs disease: psychologic care of carriers and affected families.
    Schweitzer-Miller L
    Adv Genet; 2001; 44():341-7. PubMed ID: 11596995
    [No Abstract]   [Full Text] [Related]  

  • 13. Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system.
    Miklyaeva EI; Dong W; Bureau A; Fattahie R; Xu Y; Su M; Fick GH; Huang JQ; Igdoura S; Hanai N; Gravel RA
    Brain Res; 2004 Mar; 1001(1-2):37-50. PubMed ID: 14972652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Tay-Sachs disease: a note of caution.
    Rosner F
    J Clin Ethics; 1991; 2(4):251-2. PubMed ID: 1804394
    [No Abstract]   [Full Text] [Related]  

  • 15. Tay-Sachs disease: from clinical description to molecular defect.
    Kaback MM; Desnick RJ
    Adv Genet; 2001; 44():1-9. PubMed ID: 11596975
    [No Abstract]   [Full Text] [Related]  

  • 16. Towards gene therapy for Tay-Sachs disease.
    Clyde D
    Nat Rev Genet; 2022 Apr; 23(4):197. PubMed ID: 35194181
    [No Abstract]   [Full Text] [Related]  

  • 17. Late-onset Tay-Sachs disease.
    Neudorfer O; Kolodny EH
    Isr Med Assoc J; 2004 Feb; 6(2):107-11. PubMed ID: 14986470
    [No Abstract]   [Full Text] [Related]  

  • 18. A solid start for gene therapy in Tay-Sachs disease.
    Yu TW; Bodamer O
    Nat Med; 2022 Feb; 28(2):236-237. PubMed ID: 35145310
    [No Abstract]   [Full Text] [Related]  

  • 19. Not preventing--yet, just avoiding Tay-Sachs disease.
    Scriver CR
    Adv Genet; 2001; 44():267-74. PubMed ID: 11596989
    [No Abstract]   [Full Text] [Related]  

  • 20. The Tay-Sachs disease screening program in the U.S. as a model for the control of genetic disease: an historical view.
    Edelson PJ
    Health Matrix Clevel; 1997; 7(1):125-33. PubMed ID: 10167171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.